Stock Comparison
ARGX vs BBIO
argenx NV ADR and BridgeBio Pharma Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$55.44B
$13.76B
P/E (TTM)
39.4
—
Forward P/E
34.0
—
Price/Sales
11.7
23.7
Price/Book
7.5
123.7
EV/EBITDA
33.9
-9.4
Dividend Yield
—
—
Profitability
Net Margin
31.40%
-124.40%
Operating Margin
30.00%
-54.50%
Return on Equity
20.20%
-1790.00%
Return on Assets
8.86%
-28.00%
Growth (YoY)
Revenue Growth
62.60%
66.80%
Earnings Growth
114.00%
0.00%
Price & Risk
Beta
-0.0
1.0
52-Week High
$934.62
$84.94
52-Week Low
$510.06
$41.80
Analyst Target
$1,041.14
$102.28
Compare ARGX and BBIO your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.